ORDA Featured Opportunities

Supports secondary analysis of existing datasets to accelerate substance use research. Ideal for epi and data science faculty with access to large datasets.

R01 companion — supports larger-scale secondary analyses of existing data on substance use, including health services, epidemiological, and policy research.

Supports research on ethical, legal, and social implications of genomics and genetics, including health equity, privacy, consent, and policy dimensions.

Supports clinical and applied health research across epi, biostat, environmental health, and behavioral science. Covers lifestyle interventions and health outcomes.

Joint U.S.-LMIC training grants to build infectious disease research capacity at LMIC institutions. Covers endemic diseases, NTDs, emerging infections, and microbiome/NCD connections. Supports mentored research, didactic training, and professional development over 5 years.

Supports collaborative research between U.S. and LMIC investigators. PF5 mechanism replaced traditional foreign subawards under NIH policy changes.

Supports research addressing the link between social disconnection and suicide risk in older adults, including intervention development and testing.

Supports community-level intervention research to improve minority health and reduce health disparities. Requires evidence of community engagement.

Supports investigator-initiated clinical trials focused on reducing cancer burden through early detection, screening, prevention, healthcare delivery, and survivorship.

Supports research expanding knowledge of the natural history of disorders detectable through newborn screening programs.

Supports research on non-pharmacological interventions to enhance sleep health and address sleep health disparities across populations.

Supports clinical, health services, and community-based intervention trials addressing health and healthcare disparities in NCDs among Latin American and U.S. Hispanic/Latino populations. Requires Latin American institutional partner and co-PI.

Supports multi-level and multi-domain interventions addressing disparities in liver diseases and liver cancer, including behavioral, community, and health systems approaches.

Supports population-based research identifying pathways and mechanisms through which work or occupation influences health outcomes among populations experiencing health disparities. Clinical trials optional.

Supports research testing effectiveness of navigator models that divert individuals with non-urgent mental health concerns from emergency departments to community-based services.

R34 planning grants for research on AUD treatment and recovery, including pharmacotherapy, behavioral interventions, recovery support services, and combined approaches.

R34 planning grants for pilot health services and economic research on substance use disorder treatment, including cost-effectiveness, access, and service delivery models.

R34 planning grants to develop research addressing the AUD treatment gap. Focus: treatment access, appeal, cost structures, dissemination/implementation, and health disparities.

Phased cooperative agreement supporting development of pharmacotherapies, digital therapeutics, device-based treatments, and behavioral interventions to prevent and treat SUDs and overdose. Direct costs up to $3M/year.

R34 planning grants for intervention development to improve health outcomes in American Indian and Alaska Native communities.

R01 grants for full-scale intervention research to improve health outcomes in American Indian and Alaska Native communities.

Supports bioinformatics, translational bioinformatics, and computational biology research including algorithms, tools, and data science methods for health applications.

Supports research in statistical theory, methods, and computation, including biostatistics and applications to health and life sciences data.

Broad APS through which the Dept. of State issues specific funding addenda. Faculty should monitor for addenda aligned with their work. Awards range $500K-$250M.

Community-based participatory research to optimize oral health for all through population-based interventions, policies, and programs addressing oral health disparities.

Supports translational research accelerating evidence-based addiction prevention, treatment, and recovery interventions into practice. Targets opioid crisis and overdose at individual, provider, community, and system levels. Prioritizes replicable, scalable approaches including implementation strategies and collaborative data science.